REFERENCES

^1.Albright F, Reifenstein EC.  The parathyroid glands and metabolic bone disease.  Baltimore:  Williams & Wilkins; 1948.

^2.Consensus Development Conference.  Prophylaxis and treatment of osteoporosis.  Am J Med.  1991; 90:107-10.

^3.Gambert SR, Schultz BM, Hamdy RC.  Osteoporosis:  clinical features, prevention, and treatment.  Endocrinol Metab Clin North Am.  1995; 24:317-71.

^4.Ross PD.  Osteoporosis:  frequency, consequences, and risk factors.  Arch Intern Med.  1996; 156:1399-1411.

^5.National Osteoporosis Foundation.

^6.Burger,H Vertebral deformities and functional impairment in men and women. J Bone Miner Res 1997;12: 152-7.

^7. O’Neill TW The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 1996; 11: 1010-8.

^8. Spector, T. D. Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: the Chingford Study. J Bone Miner Res 1993; 8: 817-22.

^9. Zimmerman SI, Girman CJ, Buie VC, Chandler J et al. The prevalence of osteoporosis in nursing home residents. Osteoporosis Intl 1999;9:151-157.

^10.Reginister JY, Deroisy R, Pirenne H, Fredrick I et al. High prevalence of low femoral bone mineral density in elderly women living in nursing homes on community-dwelling: A plausible role of increased parathyroid hormone secretion. Osteoporosis Intl 1999;9:121-128

^11.Goldberg TH, Restrepo MH, Tran HD: Osteoporosis in very elderly nursing home patients. Ann Long Term Care 2000;8:83-87

^12.Barrett-Connor E.  The economic and human costs of osteoporotic fracture.  Am J Med.  1995; 98(Suppl. 2A):3S-8S

return to top of page